Delivering mitochondrial health
Catharina Johansson, CFO, and Eleonor Åsander Frostner, R&D and Communications, will be presenting the company at 6:00 p.m. CEST. The event is arranged by Aktiespararna, who welcomes 40 female participants at the venue. The event can also be followed digitally.
CEO Erik Kinnman will be presenting the company at 1:05 p.m. CET.
CEO Erik Kinnman will be presenting the company at this virtual event.
Abliva will attend the digital Swiss Nordic Bio 2021. "Swiss Nordic Bio is a high-level partnering and investor conference aimed at connecting healthcare innovations, investor and industry. The conference is the number one platform that gathers life science professionals from Switzerland and the Nordic countries under one roof. The conference is organised by the Nordic countries in […]
Abliva will participate at the virtual BioStock Live on 9 March 2021. CEO Ellen Donnelly will be presenting the company. More information to come.
Abliva will participate at Aktiespararna's Aktiedagen (virtual) on 16 March 2021. CEO Ellen Donnelly will be presenting the company at 6.30 p.m. CET.
Abliva will participate at the virtual European Biotech Investor Days, Hosted by Solebury Trout. CEO Ellen Donnelly will be presenting the company on 7 April 2021, at 06:30 p.m. CEST.
Abliva will participate at Redeye's seminar on ‘Drug development in orphan indications.’ CEO Ellen Donnelly will be presenting the company at 10:55 a.m. CEST. Follow link below for further details and live webcast.
